Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Kazuki N. Sugahara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4946-192X; OpenAlex author ID A5039350018; NIH RePORTER profile ID 10430708. Sources: funder_awards.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
4
Labs led
2
Collaborators
20
Papers, trials and grants by year

2015: 1 grant · 2016: 1 grant · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 2 grants

Papers 7

  1. Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-25-4223↗
  2. A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery. Co-author DOI 10.1093/oncolo/oyaf162↗
  3. Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. Co-author DOI 10.1002/jso.27851↗
  4. Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations. Co-author DOI 10.1093/bjs/znac393↗
  5. A pancreatic cancer mouse model with human immunity Last author DOI 10.1101/2023.05.24.542127↗
  6. Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker Last author DOI 10.1101/2023.05.24.542137↗
  7. Socioeconomic Predictors of Access to Care for Patients with Operatively Managed Pancreatic Cancer in New York State. Co-author DOI 10.1007/s11605-022-05320-1↗

Grants 4

  1. Tumor-penetrating stromal modification of ß5 integrin-rich pancreatic cancer AWARD pancan:2026-kazuki-sugahara-md-phd-tumor-penetrating-stromal-modification-o
  2. Tumor-penetrating stromal modification of β5 integrin-rich pancreatic cancer R01CA307667↗
  3. The role of fibroblasts in the activities of tissue penetrating peptides R01CA167174↗
  4. Translational Research Grant: Kazuki Sugahara (tumor-penetrating peptide clinical development) AWARD pancan:2015-kazuki-sugahara-md-phd-translational-research-grant-kazuki-suga

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Moriya Tsuji · 1 shared grant, 2026 · strength 1.26
  2. Michael D. Kluger · 4 shared papers, 2022–2025 · strength 0.78
  3. Beth Schrope · 4 shared papers, 2022–2025 · strength 0.78
  4. John A. Chabot · 4 shared papers, 2022–2025 · strength 0.78
  5. Kodai Suzuki · 3 shared papers, 2023–2026 · strength 0.61
  6. Norio Miyamura · 3 shared papers, 2023–2026 · strength 0.61
  7. Andrew M. Lowy · 3 shared papers, 2023–2026 · strength 0.61
  8. Alexander S. Thomas · 3 shared papers, 2022–2024 · strength 0.55
  9. Wooil Kwon · 3 shared papers, 2022–2024 · strength 0.55
  10. Gulam Abbas Manji · 2 shared papers, 2024–2025 · strength 0.43
  11. Tatiana Hurtado de Mendoza · 2 shared papers, 2023–2026 · strength 0.43
  12. Yukihito Kuroda · 2 shared papers, 2023–2026 · strength 0.43
  13. Susan Elaine Bates · 1 shared paper, 2025 · strength 0.22
  14. Ruth Aroon White · 1 shared paper, 2025 · strength 0.22
  15. Timothy Cragin Wang · 1 shared paper, 2025 · strength 0.22
  16. Paul E. Oberstein · 1 shared paper, 2025 · strength 0.22
  17. Jeanine M. Genkinger · 1 shared paper, 2024 · strength 0.21
  18. Neha Goel · 1 shared paper, 2023 · strength 0.17
  19. Andrew D. Rhim · 1 shared paper, 2023 · strength 0.17
  20. Kenneth P. Olive · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.